Gemcitabine/Carboplatin in Patients with Metastatic Non–Small-Cell Lung Cancer: Phase II Study of 28-Day and 21-Day Schedules
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 7 (3) , 202-207
- https://doi.org/10.3816/clc.2005.n.037
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinomaCancer, 2003
- Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Gemcitabine/carboplatin in advanced non-small cell lung cancerLung Cancer, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trialLung Cancer, 2001
- The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancerLung Cancer, 2000
- A Phase II Study of Carboplatin Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer (NSCLC)American Journal of Clinical Oncology, 1999
- Phase I-II Study of Gemcitabine and Carboplatin in Stage IIIB-IV Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Chemotherapy for advanced non-small-cell lung cancerRespiratory Medicine, 1994
- Screening, diagnosis, and staging of lung cancerCurrent Opinion in Oncology, 1993